Search

everythinglearnresearchcommunity

for

Search:↓

The mineralocorticoid receptor may play a role in skin and hair health and could be a new target for treating related disorders.

Finasteride effectively reduces hair growth in women with polycystic ovary syndrome or idiopathic hirsutism.

Testosterone therapy is beneficial for women's health and does not cause masculinization or liver damage, and it protects the heart and breasts.

People with hair loss have higher risk of high blood sugar and diabetes, and lower levels of a specific hormone.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

Hair growth slows and shedding increases after childbirth, but most women don't experience excessive hair loss.

Epilepsy and certain epilepsy drugs can lead to reproductive problems in women, but changing medication might improve these issues.

Finasteride reduces alcohol withdrawal severity in male mice but increases it in female mice.

FPHL common in Taiwanese women; risk factors include BMI, high glucose, early puberty, fewer childbirths, oral contraceptives, and UV exposure.

Early adrenal gland maturation in young children can be normal, but other serious conditions should be ruled out first.

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.

LPA3 is crucial for embryo implantation and links LPA to prostaglandin signaling.

5-alpha-reductase inhibitors may cause a low incidence of erectile dysfunction that decreases over time.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

Genetics affect early female hair loss, severity depends on duration, and low ferritin levels not significant.

The document concludes that there is a significant lack of reporting on the sex and age of cells in skin research, which could affect clinical trials and treatments.

Dutasteride protects dopamine neurons in Parkinson's mice, but Finasteride doesn't.

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.

Hormonal treatments can improve acne, but they come with potential side effects and risks.

Hormonal changes after childbirth and menopause can lead to women's hair loss and facial hair growth, with a need for better treatments.

Most skin changes during pregnancy are harmless and temporary, but some can risk the fetus and need careful treatment.

Treatment during development affects hormone balance and sexual behavior in male rats.

Cholesterol balance is important for hair health, and problems with it can lead to hair loss conditions.

Using anabolic androgenic steroids can cause serious, lasting health problems in many parts of the body.

Certain SHBG gene variants, like rs727428, are linked to higher testosterone levels in women with PCOS.

Some skin conditions are common during pregnancy and can be safely treated without affecting the pregnancy outcome.

Most pregnant women experience skin changes like darkening and itching, while serious skin conditions are rare but need early treatment.

The document concludes that health care providers should offer culturally competent care and more research is needed to improve health outcomes for transgender individuals.